ASPB responds to FDA RFI on the Coordinated Framework

ASPB responds to Response to FDA-2015-N-3403: Clarifying Current Roles and Responsibilities Described in the Coordinated Framework for the Regulation of Biotechnology and Developing a Long-Term Strategy for the Regulation of the Products of Biotechnology; Request for Information.

Since the first introduction of biotechnology-derived plant products, not a single documented issue with regard to human safety has arisen. From the human health perspective, the current system has proven to be effective. There can be no question that concerning human health, the current system has worked effectively for over two decades. There is a case to be made that regulatory barriers are too high and the current one-size-fits-all model does not serve the public good.

Read the full ASPB response.

Leave a Comment